Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall St futures mixed as tech wobbles again, Tesla gains
- Oil eases but heads for small weekly gain as investors focus on Middle East supply
- U.S. producer prices rise by 1.3% month-on-month in September
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Chromalux Corp (NYSE: CHRO) | Delayed: 1.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.35 | 52 Week High | $0.06 | |||
| Open | $1.35 | 52 Week Low | $0.01 | |||
| Day High | $1.35 | P/E | N/A | |||
| Day Low | $1.35 | EPS | $0.00 | |||
| Volume | 163 | |||||
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 298.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $298.50 | 52 Week High | $139.79 | |||
| Open | $298.50 | 52 Week Low | $82.07 | |||
| Day High | $298.50 | P/E | 694.19 | |||
| Day Low | $298.50 | EPS | $0.43 | |||
| Volume | 9 | |||||
